# A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

> **NCT01373567** · PHASE4 · COMPLETED · sponsor: **Piramal Enterprises Limited** · enrollment: 298 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** TINEFCON

## Key facts

- **NCT ID:** NCT01373567
- **Lead sponsor:** Piramal Enterprises Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-06
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2012-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01373567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01373567, "A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01373567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*